Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
Clinical trial NCT04539262 · COMPLETED
Trial details
- NCT number
- NCT04539262
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2021-02-26
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.